News About: Pharm. Industry
What are results of Eastern Branch of Busan District Public Prosecutors’ Office’s rebate investigation for wholesalers?
The Eastern Branch of Busan District Public Prosecutors’ Office is expected to decide whether to indict the wholesalers for rebates within this month.
According to the industry concerned, the prosecutors’ office is k...
Definition of ‘Financial Benefits’ raised at Novartis rebate trial
While the Novartis’s rebate trial continues, a definition of the ‘provision of financial benefits,’ which the prosecution claimed as a base of indictment, became a topic of conversation at the trial.
The defense argu...
World’s top condom manufacturing company Ansell enter Korea with ‘LifeStyles’
Ansell, the world’s top condom manufacturing company which makes about 2.2 billion condoms a year, will land on Korea with its condom brand ‘LifeStyles.’
Ansell with a history of 110 years is the oldest condom maker ...
Bulim Pharm sweeps Pusan National University Yangsan Hospital’s tenders of annual KRW 60 billion medicine supply
Bulim Pharm made a sweep of the wins at tenders for university hospitals in the Busan area.
At the Pusan National University Yangsan Hospital’s medicine tender on the 19th for an yearly amount of medicines worth of K...
Peak seasons for different medical departments
Different medical departments have a different season to have a crowd of patients. A department of ophthalmology gets busy with eye trouble patients during summer due to swimming, and a peak season for orthopedics is ...
‘Zemiglo trial’ prolonged for a while, expected to take even longer
The Zemiglo license lawsuit between LG Chem(former LG Life Sciences) and Sanofi-Aventis has been prolonged due to several changes of date.
On the 14th, the 17th Civil Division at the Seoul Central District Court deli...
Kolon Life Science conducts overseas marketing services to attract foreign patients for ‘Invossa’
Kolon Life Science(CEO Woo-Seok Lee) announced on the 13th that the company signed a strategic MOU for Invossa K Inj to attract foreign patients with the Korea Medical Tourism Promotion Association(President Chun-Ki J...
Loopholes of preferential sale approval system causes damages on pharmas
Loopholes of the preferential sale approval system, which was implemented to shorten times to commercialize generics drugs by nullifying an original product’s patent, have caused delays for generics to be launched eve...
Tonymoly gives up acquisition of Tai Guk Pharm, largest dermatologic product company
Tonymoly, a cosmetic brand, gave an official notice to acquire Tai Guk Pharm(decided to acquire 5.826 million shares, KRW 14 billion), the Korea’s largest pharmaceutical company specializing in dermatologic products, ...
Daewoong Pharmaceutical acquires preferential sale right in KRW 150 billion hepatitis B generic marketDaewoong Pharmaceutical will enter the market of ‘tenofovir,’ a hepatitis B treatment, worth of approximately KRW 150 billion.
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announ...
|
